Right ventricular outflow tract obstruction risk factors: Difference between revisions
Jump to navigation
Jump to search
(New page: {{CMG}} A recent review by the Mayo clinic does not support the role of SSRIs in the development of congenital heart disease. <ref name="pmid19121250">{{cite journal| author=Wichman CL, ...) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Right ventricular outflow obstruction}} | |||
{{CMG}} | {{CMG}} | ||
A recent review by the Mayo clinic does not support the role of SSRIs in the development of congenital heart disease. <ref name="pmid19121250">{{cite journal| author=Wichman CL, Moore KM, Lang TR, St Sauver JL, Heise RH, Watson WJ| title=Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. | journal=Mayo Clin Proc | year= 2009 | volume= 84 | issue= 1 | pages= 23-7 | pmid=19121250 | doi= | pmc=PMC2664566 | url= }} </ref> | A recent review by the Mayo clinic does not support the role of SSRIs in the development of congenital heart disease. <ref name="pmid19121250">{{cite journal| author=Wichman CL, Moore KM, Lang TR, St Sauver JL, Heise RH, Watson WJ| title=Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. | journal=Mayo Clin Proc | year= 2009 | volume= 84 | issue= 1 | pages= 23-7 | pmid=19121250 | doi= | pmc=PMC2664566 | url= }} </ref> | ||
==References== | |||
{{reflist|2}} | |||
Revision as of 16:30, 24 June 2011
Template:Right ventricular outflow obstruction
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
A recent review by the Mayo clinic does not support the role of SSRIs in the development of congenital heart disease. [1]